$3.13 Billion is the total value of Hillhouse Capital Management's 35 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ESGR | ENSTAR GROUP LIMITED | $209,895,000 | +0.2% | 1,204,353 | 0.0% | 6.70% | -23.4% | |
| BGNE | BEIGENE LTDsponsored adr | $128,202,000 | -6.1% | 1,034,306 | 0.0% | 4.09% | -28.2% | |
| CVET | COVETRUS INC | $114,177,000 | -23.2% | 4,667,925 | 0.0% | 3.64% | -41.3% | |
| GOSS | GOSSAMER BIO INC | $110,324,000 | +2.4% | 4,974,041 | 0.0% | 3.52% | -21.7% | |
| APLS | APELLIS PHARMACEUTICALS INC | $53,178,000 | +29.9% | 2,098,581 | 0.0% | 1.70% | -0.6% | |
| AAPL | APPLE INC | $25,286,000 | +4.2% | 127,759 | 0.0% | 0.81% | -20.3% | |
| MELI | MERCADOLIBRE INC | $19,944,000 | +20.5% | 32,600 | 0.0% | 0.64% | -8.0% | |
| JD | JD COM INCspon adr cl a | $16,914,000 | +0.5% | 558,400 | 0.0% | 0.54% | -23.1% | |
| MRNA | MODERNA INC | $14,324,000 | -28.1% | 978,434 | 0.0% | 0.46% | -45.0% | |
| CJJD | CHINA JO-JO DRUGSTORES INC | $5,372,000 | -57.6% | 4,840,000 | 0.0% | 0.17% | -67.7% | |
| ARVN | ARVINAS INC | $5,064,000 | +49.0% | 230,308 | 0.0% | 0.16% | +14.1% | |
| TCRR | TCR2 THERAPEUTICS INC | $4,621,000 | -17.9% | 322,903 | 0.0% | 0.15% | -37.4% | |
| CNST | CONSTELLATION PHARMCETICLS I | $3,904,000 | -9.4% | 317,921 | 0.0% | 0.12% | -30.6% | |
| RCUS | ARCUS BIOSCIENCES INC | $2,720,000 | -36.3% | 342,128 | 0.0% | 0.09% | -51.1% | |
| NTGN | NEON THERAPEUTICS INC | $1,893,000 | -26.6% | 399,308 | 0.0% | 0.06% | -44.4% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MONDELEZ INTL INC | 22 | Q3 2018 | 44.4% |
| JD COM INC | 19 | Q2 2019 | 80.2% |
| SOHU COM INC | 19 | Q1 2018 | 13.4% |
| 58 COM INC | 18 | Q3 2018 | 7.8% |
| TAL EDUCATION GROUP | 18 | Q2 2019 | 4.4% |
| CTRIP COM INTL LTD | 17 | Q2 2017 | 28.4% |
| BEIGENE LTD | 14 | Q2 2019 | 25.2% |
| MELCO RESORT ENTERTAINMENT L | 14 | Q3 2018 | 6.4% |
| CAMECO CORP | 14 | Q4 2017 | 2.2% |
| ENSTAR GROUP LIMITED | 12 | Q2 2019 | 21.9% |
View Hillhouse Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| China Jo-Jo Drugstores Holdings, Inc. | February 14, 2023 | 403,334 | 4.7% |
| TScan Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Enfusion, Inc. | February 14, 2022 | 4,975,183 | 7.6% |
| Enstar Group LTD | July 19, 2021 | ? | ? |
| Zoom Video Communications, Inc. | February 16, 2021 | 2,981,265 | 1.5% |
| NIO Inc. | February 14, 2020 | ? | ? |
| Sea Ltd | February 14, 2020 | 4,300,000 | 2.3% |
| Uxin Ltd | February 14, 2020 | 21,733,023 | 2.6% |
| Apellis Pharmaceuticals, Inc. | February 14, 2019 | 2,098,581 | 3.7% |
| iQIYI, Inc. | February 14, 2019 | 240,191,174 | 11.0% |
View Hillhouse Capital Management's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13G/A | 2024-03-05 |
| 13F-NT | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 4 | 2024-02-01 |
| 3 | 2024-01-25 |
| 13F-NT | 2023-11-14 |
| 13F-NT | 2023-08-14 |
View Hillhouse Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.